In the current month, AEON has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AEON average Analyst price target in the last month is 1.820.
Based on analysts' estimates, AEON EPS is projected to reach -0.080 in FY2026Q3, following reported EPS of -0.023 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.02, while Aeon Biopharma IncAEON's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.08.